Simple Summary Triple-negative breast cancer (TNBC) is an aggressive type of cancer that
is challenging to treat due to the lack of hormonal receptors used to target cancer cells; due …

Triple-negative breast cancer (TNBC) is unresponsive to typical hormonal treatments,
causing it to be one of the deadliest forms of breast cancer. Investigating alternative …

Breast cancer is a significant threat to women's health and has high incidence and mortality.
Metastasis in breast cancer patients is a major cause of cancer deaths among women …

Triple-negative (ER-/PR-/HER2-) breast cancer (TNBC) is a severe clinical problem because
of its relatively poorer prognosis, aggressive behavior and lack of targeted therapies …

Protein kinase dysregulation induces cancer cell aggressiveness leading to rapid tumor
progression and poor prognosis in TNBC patients. Many small-molecule kinase inhibitors …

Purpose Although paclitaxel is widely used in cancer treatment, severe side effects and drug
resistance limit its clinical use. 10-gingerol (10-G) is a natural compound isolated from …

Background: Studies have shown that the natural products of Astragalus membranaceus
(AM) can effectively interfere with a variety of cancers, but their mechanism of action on …

Triple negative breast cancer (TNBC) is a highly metastatic cancer among the breast cancer
subgroups. A thorny issue for clinical therapy of TNBC is lack of an efficient targeted …

Abstract Triple-Negative Breast Cancer (TNBC) is a most dangerous breast cancer subtype.
The naturally occurring sesquiterpene lactone, arnicolide D (AD), has proven effective …

Triple-negative breast cancer (TNBC) is a lethal malignancy without safe and effective
therapeutic drugs. In this study, the anti-TNBC bioassay-guided isolation of the medicinal …